With respect to lifestyle factors predicting response, a recent systematic review and meta-analysis has quantified the effect of obesity on response to anti TNFα therapy across a range of immune-mediated inflammatory diseases. Here, TNF is linked to obesity due to melanocortin 4 receptor deficiency.